Printer Friendly

ANALYST INTERVIEW: SPECIALTY PHARMACEUTICAL COMPANIES: GARY NACHMAN - LEERINK SWANN & COMPANY.

(ZBI800) SPECIALTY PHARMACEUTICAL COMPANIES: GARY NACHMAN - LEERINK SWANN & COMPANY. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Pharmaceuticals. Published date 1/9/06. Tickers featured: AGN, BSX, BTRX, BVF, CNCT, ENDP, FRX, GDT, IMDC, IVX, JNJ, MNT, MRX, PFE, PPCO, SEPR, TEVA. Complete text approximately 3000 words. Document # ZBI800.

ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: information@twst.com.
COPYRIGHT 2006 Wall Street Transcript Corporation
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Wall Street Transcript Digest
Date:Jan 9, 2006
Words:112
Previous Article:ANALYST INTERVIEW: SPECIALTY PHARMACEUTICALS & GENERICS: ROBERT UHL - FRIEDMAN, BILLINGS, RAMSEY GROUP INC.
Next Article:MONEY MANAGER INTERVIEW: SARAT SETHI - DOUGLAS C. LANE & ASSOCIATES.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters